Genome-wide association study of paliperidone efficacy

OBJECTIVE Clinical response to the atypical antipsychotic paliperidone is known to vary among schizophrenic patients. We carried out a genome-wide association study to identify common genetic variants predictive of paliperidone efficacy. METHODS We leveraged a collection of 1390 samples from individuals of European ancestry enrolled in 12 clinical studies… CONTINUE READING